Recent Headlines
Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert
The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding
AveXis Announces Opening of Enrollment for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children's Hospital
AveXis, Inc., a clinic-ready synthetic biology platform company, today announced that the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now formally begun enrollment at Nationwide Children’s Hospital. This trial will utilize chariSMA, the gene therapy product developed... - May 16, 2014 - AveXis Inc.
MiTeGen Announces Collaboration and License Agreements with MagnebotiX and NatX-ray
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed agreements with MagnebotiX AG, and with NatX-ray SAS, and NatX-ray LLC for the development and distribution of RodBot non-contact magnetic rolling sample manipulation technology for crystallization and crystal handling. - May 14, 2014 - MiTeGen, LLC
VIRUN NutraBIOsciences™, Leader in Cognitive-Functional-Ingredients, to Sponsor Cognitive Health Forum at NutraIngredients-USA
VIRUN, leader in Cognitive health ingredients, is sponsoring NutraIngreidents Cognitive Health Forum on May 22nd, 2014. According to NutraIngredients-USA, “Industry leaders from companies such as Abbott Nutrition, Standard Process, Nawgan, and Euromonitor will join for a discussion of the cognitive health sector, from science and claim substantiation, to market sizing and key consumer demographics.” - May 13, 2014 - VIRUN
MoBiTec GmbH to Attend the International Conference on Stem Cell and Tissue Formation in Dresden, Germany, from July 8-11, 2014
For the 5th time, Stem Cell researchers will convene for the International Conference on Stem Cell and Tissue Formation in Dresden, Germany. At MoBiTec's booth high quality products as well as cutting-edge technologies will be presented. - May 09, 2014 - MoBiTec GmbH
Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products
Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014 - Xcelthera Inc
MoBiTec GmbH, Germany, Issues New Fluorescent Probes Brochure, Ready for Free Download as PDF
A brochure featuring Fluorescent Probes for Protein and Nucleic Acid Labeling provided by MoBiTec as Free PDF Download. - May 08, 2014 - MoBiTec GmbH
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
Solanbridge Group (SLNX) has hired Dr. Mark Cullen to develop CBD-enfused products for the State of Nevada. - May 02, 2014 - Solanbridge Group Inc
BiologicsCorp Launches Supernatant Protein Expression Service
BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp
AveXis Closes a Round of Financing from PBM Capital to Advance Its SMA Gene Therapy Program
AveXis, Inc., a clinic-ready synthetic biology platform company, today announced it has completed a financing round led by PBM Capital Group. This round of financing will help support the company’s gene therapy program targeting spinal muscular atrophy (SMA). AveXis’ gene therapy... - April 23, 2014 - AveXis Inc.
Women Found to be at Greater Risk for Alzheimer’s - Find Solution with MentScan from MMT
Women with Alzheimer’s Gene fight back with MMT’s screening test called the MentScan. - April 18, 2014 - MD Stem Cells
MD Stem Cells Names Top 7 Recent Stem Cell Advances
7 key advances in Stem Cell treatments and research identified by MD Stem Cells. - April 17, 2014 - MD Stem Cells
Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board
Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members. - April 12, 2014 - Recursion Pharmaceuticals
Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo
Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo
Dr. Applegate to Join Advisory Board at Peptineo
Peptineo is pleased to welcome Dr. Robert Applegate to the advisory board of Peptineo. Dr. Applegate is a recognized expert in microfluidics, biomedical devices and optical technologies. As a result of his research, Dr. Applegate holds patents in optical trapping, cell diagnostics and sorting, and... - April 07, 2014 - Peptineo
Peptineo, a Biotechnology Company Focused on Value Recovery in Pharma, Announces the Appointment of Kamal Garcha PhD., to Advisory Board
"We welcome the addition of Dr. Garcha," noted Sheldon K. Jordan, PhD, CEO. Dr. Garcha holds an Honor’s BSC in Cell Biology and MSc. in Zoology from Western University, and a PhD. in Cellular & Physiological Sciences from the University of British Columbia. During the course of... - April 02, 2014 - Peptineo
OsoBio Appoints Catherine Buck Director of Manufacturing
Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014 - OSO BioPharmaceuticals Manufacturing, LLC
Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization
Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo
Peptineo Announces Appointment of David M. Wyatt to Advisory Board
Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo
Dr. Sundar Nadarajan Joins the Advisory Board at Peptineo to Guide Nanotechnology Drug Delivery Platform for Protein Therapeutics
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Sundar Nadarajan, PhD, to the company's Scientific Advisory Board. They are extremely pleased that Dr. Nadarajan has joined the Peptineo Scientific Advisory Board. "He is an accomplished scientist and consulting... - March 27, 2014 - Peptineo
MoBiTec GmbH Offers MagSi-NGS/PREP Kit for Next Generation Sequencing (NGS) Library Clean-Up
Magnetic bead-based MagSi-NGS/PREP kit constitutes an efficient solution for clean-up and size selection in library preparation of NGS sequencing reactions. The simple, flexible protocol can be adjusted to any specific application and NGS platform. - March 27, 2014 - MoBiTec GmbH
Pioneers in Adult Stem Cell Therapy Honored
The Alliance for the Advancement of Adult Stem Cell Therapy and Research hosted an awards luncheon for doctors and patients from around the world to recognize and honor their outstanding contributions and achievements in adult stem cell therapy. The Stem Cell Alliance event celebrated the revolutionary strides in the field of adult stem cell treatments for cardiac, pulmonary, neurological, spinal cord injuries and vascular diseases. - March 26, 2014 - Regenocyte Worldwide
Exova Wins Major Defence Contract
Exova, the global testing, calibration and advisory services provider, has won a major contract with FMV, the Swedish Defence Material Administration, worth a potential £24.5 million over seven years. - March 21, 2014 - Exova
NeoStrata Canada Struts Runway-Ready Skin at World MasterCard Fashion Week
NeoStrata Canada teams up with high fashion as the Official Skin Care and Anti-Aging Treatments Sponsor of World MasterCard® Fashion Week (WMCFW) in Toronto, running from March 17 to 21. WMCFW attendees and beauty editors can visit the NeoStrata booth on site or access content, tips and... - March 15, 2014 - Sanofi Canada
Creative Biomart Launches New Services: Protein Labeling & Conjugation
Creative Biomart has announced the launch of a new offering for protein labeling and conjugation. - March 13, 2014 - Creative Biomart
CovalX and ASPEC Technologies Limited Announce Partnership for Distribution of CovalX’s High-Mass Systems in China
Providing the greater China region with sales, marketing and support to CovalX’s unique technologies for protein interaction and macromolecular analysis by mass spectrometry. - March 01, 2014 - CovalX
AnaSpec Now Offers 5-Hydroxymethyl Cytosine Monoclonal Antibody (Clone 4D9)
A mouse monoclonal antibody specifically recognizing 5-hydroxymethyl Cytosine (5-hmC) is now available from AnaSpec. - February 21, 2014 - AnaSpec, EGT Group
HeMemics Announces Election of Larry Simpson to Its Board of Directors
Election of Larry Simpson to HeMemics Board of Directors - February 15, 2014 - HeMemics Biotech
HeMemics Type C Meeting with FDA Blood Applications Division
HeMemics to meet with the FDA to discuss which of the available paths that HeMemics Platelet Additive Solution (HemSol™) may take in pursuit of FDA approval and commercialization - February 15, 2014 - HeMemics Biotech
Dr. Emil J. Haldey to Address Physicians in Field of Podiatric Medicine
Joint Session of American Board of Foot Surgeons and American Association of Medical Foot Specialists to welcome pharmaceutical compounding expert. - February 12, 2014 - HALDEY Pharmaceutical Compounding
SFL Experts to Present and Chair Sessions at the 2014 DIA Annual Euromeeting in Vienna
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector at 2014 DIA Annual EuroMeeting. - February 12, 2014 - SFL Regulatory Affairs & Scientific Communication Ltd
VIRUN® & Amway Open Innovation Push for More Creativity and Technology; Introducing Unknown Thoughts in Industry
Virun, and Amway Open Innovation, team-up to express their interest and efforts to foster creativity, invention, and innovation with foods, beverages and supplements. New product development is more difficult today than ever before; increased regulations, competition, market saturation and consumer perception make it difficult to introduce new products that, not only stand-out, but are what consumers will purchase and re-purchase. - February 11, 2014 - VIRUN
MoBiTec Offers CytoCapture-Cell Culture Dishes and Chambers for Single Cell Analysis of Small Non-Adherent Cells
CytoCapture dishes and chambers enable the analysis of small non-adherent cells, exposure studies with time dependent reactions, multiple staining and high resolution microscopy of non-adherent cells, and Laser Scanning Confocal Microscopy (LSM). - February 05, 2014 - MoBiTec GmbH
EightSpokes Announces the Launch of Their Online Presence
EightSpokes, creators of Enlighten, a SaaS-based commercial excellence platform designed with life science companies in mind, announces the launch of their online presence, EightSpokes.com. The website highlights the “Noble Eightfold Path” that inspired the company’s approach to make work more rewarding. Enlighten adopts proven social collaboration technologies and ideas from industry leaders to put teams and team members at the center of every project’s successful execution. - January 29, 2014 - EightSpokes
Dr. George Tegos Joins Advisory Board at Peptineo to Guide Antimicrobial Pipeline and Technology Development
Peptineo, a biotechnology company focused on value recovery in Pharma, announces the appointment of George Tegos, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Tegos has joined the Peptineo Scientific Advisory Board. Dr. Tegos is recognized as an emerging... - January 29, 2014 - Peptineo
MoBiTec, Germany, Offers Constitutive Gene Expression System for Lactococcus Lactis and Other Lactic Acid Bacteria
The Constitutive Gene Expression System for Lactococcus lactis and Other Lactic Acid Bacteria, developed by NIZO food research BV, The Netherlands, is easy-to operate and has advantages for many applications like overexpression of homologous and heterologous genes. With this new system MoBiTec expands its rich portfolio of non-E. coli vectors and expression systems. - January 19, 2014 - MoBiTec GmbH
Exova Metech Secures Outsourcing Deal with Vestas
Exova Metech, the calibration and metrology division of Exova, the global testing, calibration and advisory services provider, has won an outsourcing deal with the leading wind turbine manufacturer, Vestas, to become its preferred supplier of calibration services. Exova Metech will now acquire the... - January 18, 2014 - Exova
Dr. Eric Bachelder Joins Advisory Board at Peptineo
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Eric Bachelder, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Bachelder has joined the Peptineo Scientific Advisory Board. Dr. Bachelder is recognized as an emerging... - January 18, 2014 - Peptineo
Kimberley Beauford Joins Peptineo as Vice President of Human Capital
Industry veteran and accomplished executive, Kimberley Beauford has joined Peptineo as its new vice president of human capital. Beauford brings over 14 years of proven expertise in the delivery of innovative, strategic human capital programs to the finance and healthcare industries. Prior to... - January 14, 2014 - Peptineo
Cambridge Healthtech Institute Announces Its Inaugural Biologics Formulation & Delivery Summit
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon - January 12, 2014 - Cambridge Healthtech Institute
Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants
Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative Biomart
Creative Diagnostics Launches Its Rapid Malaria Test Kit for Diagnostic Use
As a leading manufacturer and supplier of antibodies and diagnostic components, Creative Diagnostics has launched its innovative malaria testing kit. - January 04, 2014 - Creative Diagnostics
CHI's 5th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, February 4-6, 2014
700+ industry executives to gather for solutions on various aspects of clinical trial planning and management at 11 conferences, 7 short courses, breakout discussion groups, networking functions, while also viewing an expansive exhibit hall. - January 02, 2014 - Cambridge Healthtech Institute
OsoBio Reaffirms DCAT Partnership Through New Leadership Positions
OsoBio President Milton Boyer to serve as vice president of DCAT's executive committee. - December 19, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
MiTeGen Announces Online Beamline Guide for Structural Biologists
MiTeGen LLC, a provider of innovative consumables for protein crystallization, crystallography and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has released an Online Beamline Guide for crystallographers and structural biologists. - December 18, 2013 - MiTeGen, LLC
Leber Hereditary Optic Neuropathy May Benefit from Stem Cell Eye Treatment
MD Stem Cells hopeful that SCOTS stem cell eye study will benefit blinding eye disease caused by damaged energy producing organelles of optic nerve. - December 18, 2013 - MD Stem Cells
Peptineo Inks Exclusive Option for Drug Delivery Technologies
Peptineo, a privately held biotechnology company, announced today that the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery. Under this agreement, Peptineo will work to commercialize drug delivery technologies developed in the laboratories... - December 10, 2013 - Peptineo
SFL Managing Director Provides Further Update Regarding Revision of EU Medtech Legislation
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation. - November 21, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Dr. Emil J. Haldey to Speak Before Medical Society of the State of New York
Dr. Emil J. Haldey, President of New York City-based HALDEY Pharmaceutical Compounding, will speak later this week before an audience of doctors at First District Branch of the Medical Society of the State of New York (MSSNY). MSSNY’s First Branch includes all five boroughs of New York... - November 20, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions
In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative Biomart